4//SEC Filing
Griffin Deborah A 4
Accession 0001209191-19-050263
CIK 0000818686other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 7:12 AM ET
Size
9.5 KB
Accession
0001209191-19-050263
Insider Transaction Report
Form 4
Griffin Deborah A
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2019-09-18+2,376→ 2,376 total - Exercise/Conversion
Restricted Share Units
2019-09-18−2,376→ 0 total→ Ordinary Shares (2,376 underlying) - Sale
Ordinary Shares
2019-09-18$7.83/sh−2,376$18,607→ 0 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.82 to $7.835, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Restricted share units were granted on September 18, 2017, with 2,376 vesting on each of September 18, 2018 and September 18, 2019.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001719115
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 7:12 AM ET
- Size
- 9.5 KB